Clinical reviewer: Dr. Sarah Boss, MD

COGNIFUL publishes this guide as part of THE BALANCE GROUP and includes its residence in Mallorca, Spain. It does not operate a verified Swiss treatment facility. The Swiss providers are selected official-source examples, not an independent ranking. Their inclusion does not imply identical admission conditions or luxury accommodation.

Dual diagnosis commonly means a substance-use disorder occurring with another mental health disorder. It is not one fixed diagnosis or a reliable explanation of what caused what. NIMH describes a complex relationship and emphasizes comprehensive assessment because symptoms can overlap. [1]

Describe changes in substance use and mental health over time. Include medication, physical health, previous treatment and periods when symptoms or functioning improved. If the sequence is uncertain, explain the uncertainty rather than supply a neat causal story.

Ask what the assessment is expected to clarify. The immediate plan may be clear while some diagnostic questions remain open. The team should explain which decisions need further observation and who will review them.

The hospital pathways and COGNIFUL’s shared residence have different capabilities. Ask the relevant service to assess suitability rather than infer it from a provider’s broad treatment scope or private status.

The Zurich service describes adults aged eighteen to sixty-five, with preference for residents of Canton Zurich. Its clinical options vary by setting and can include assessment, withdrawal treatment, psychiatric care and coordination with ongoing services. The specific pathway and access conditions should be confirmed directly. [2]

Psychiatric Services Aargau describes inpatient care in Windisch, including specialized addiction and acute dual-diagnosis services. Outpatient arrangements in Windisch, Aarau and Baden have distinct clinical roles. Ask which site and service match the needs rather than assuming every offer is available at every address. [3]

Financial eligibility and treatment language also need direct discussion. A university, cantonal or private affiliation does not establish the terms for an individual applicant. Obtain the actual admission and payment information before organizing the next phase.

NIMH describes integrated treatment as bringing mental health and substance-use care together, potentially using behavioral therapies, medication and care management. The relevant professionals should understand how their work connects to the whole plan. [1]

Ask who coordinates the assessment and who is responsible for each priority. If addiction treatment, psychotherapy and psychiatric care involve different people, find out how recommendations are shared and reviewed. The person should not be left to reconcile conflicting advice alone.

A good explanation identifies the immediate needs, the work planned next and the uncertainties that remain. It should be possible to understand why the recommended setting is appropriate without relying on a long list of diagnostic terms.

Ask how changes in one area affect the other parts of the plan. Improved mood does not automatically settle a substance-use concern, and reduced use does not prove that all mental health symptoms have resolved. Review should include daily functioning as well as each clinical area.

Possible withdrawal should be assessed before a person changes use or travels. Explain previous withdrawal experiences, medical concerns and the complete pattern of substance and medication use. Do not abruptly stop alcohol or a prescription simply to prepare for admission.

ASAM states that alcohol withdrawal management alone is not sufficient treatment for alcohol use disorder. It should connect with ongoing care. A dual-diagnosis plan also needs to explain the mental health work that continues after any immediate withdrawal needs are addressed. [5]

In opioid use disorder, CDC advises against detoxification alone without medication treatment. Ask an appropriate addiction clinician to explain the evidence-based care and continuity required for your circumstances. A move between countries or settings should not create an unplanned break in treatment. [6]

COGNIFUL in Mallorca, Spain, offers detoxification as part of its addiction treatment pathway. Clinical assessment determines the appropriate care plan and setting. In some cases, treatment may begin with an initial 1–3 days in a partner hospital for observation and stabilization before continuing at COGNIFUL. The pathway is planned around each person’s medical needs. Acute medical, psychiatric or withdrawal needs may require another service first. The clinical review should determine when the person is suitable for the proposed residential phase. [7]

COGNIFUL’s co-occurring-needs assessment considers mental health symptoms, substance use, medication, physical health, treatment history and functioning together. A personal plan follows the review of whether the shared residence can meet the combination of needs. Any separate clinical arrangements should be explicit. [4]

COGNIFUL Premier and Premier Plus accommodate a maximum of four clients at any time, with a private suite for each person. Clinical and bodywork sessions are individual. The residence, chef, personal manager, other holistic sessions, excursions and activities are shared. Discuss whether that daily format fits the assessed support needs and personal preferences. [8]

The client maximum is a capacity limit, not a staffing ratio or guarantee of a particular clinical method. Ask the proposal to name the professional roles, individual work and arrangements for medical or psychiatric input where relevant. Do not infer universal access to every clinician from shared team information.

COGNIFUL Premier and Premier Plus both include assessment, a personal plan and continuing-care planning. COGNIFUL Premier Plus adds individual therapeutic work, family and transition work, and three months of aftercare. Base-program follow-up is agreed individually. The typical four-to-twelve-week stay is reviewed for the person rather than treated as a fixed recovery deadline. [9] View program fees

For a Swiss resident, the added transition work should relate to the actual next phase. Ask how the stay connects with local addiction and mental health professionals, family support or a return to responsibilities. Each program component should have an understandable purpose.

Continuing-care planning considers everyday routines, relationships, local support and authorized professional coordination. Confirm which services are included after departure and which require local arrangements. An aftercare period does not establish unrestricted cross-border prescribing or remote treatment. [10]

COGNIFUL generally operates on a self-pay basis, does not bill insurers directly and cannot guarantee reimbursement. A written admissions proposal should confirm the complete services, costs, inclusions and separate arrangements. Compare that full pathway with an appropriate Swiss option before committing.

Taking prescribed medication does not by itself establish an addiction. COGNIFUL’s co-occurring guidance distinguishes the original treatment need, physical dependence, withdrawal and a substance-use disorder. Ask the assessing professional to clarify these questions in the individual case. [4]

Provide prescribed instructions and actual use, including non-prescription products and recent changes. Ask who reviews benefits, unwanted effects and interactions. If more than one prescriber is involved, the plan should explain how the information is brought together.

A residential transition should not require the person to choose between conflicting recommendations without clinical support. The responsible professionals should review the issue and explain the agreed next step.

Confirm the working language of the actual assessment, psychotherapy and medical conversations. A provider’s translated pages or multilingual coordinator do not establish that every part of care is available in the same language.

For a Mallorca stay, arrange how the Swiss receiving clinicians will obtain usable information. The summary should explain the assessment, work completed, medication responsibilities and questions still open. Agree on the language and authorized method of transfer.

If you expect to move within Switzerland or travel frequently after treatment, disclose that before the plan is finalized. The continuing appointments should fit the place where you will actually live and the services available there.

NIMH identifies behavioral approaches such as CBT, motivational interviewing and contingency management as possible parts of treatment for co-occurring needs. Ask which approach is proposed, what it addresses and who is qualified to deliver it. The presence of several therapy names on a website does not establish that all are relevant to one person. [1]

Describe any difficulties with earlier treatment, including practical barriers or uncertainty about its purpose. The next clinician should use that information to explain a plan that is feasible and understandable. If the person is unsure about change, that concern belongs in the clinical conversation rather than being treated as an administrative obstacle.

A family member may help with transport, payment or an agreed part of treatment. Clarify each role and what information may be shared. Financial involvement does not automatically settle access to sensitive clinical details.

If family work is proposed, ask what it is intended to achieve and how the person’s consent is handled. The program should not assume that every relationship is appropriate to involve in the same way.

Ask how substance use, mental health symptoms and everyday functioning will be considered together. A single measure or a short period of improvement cannot answer every question about the person’s needs.

Discuss what happens when symptoms change or participation becomes difficult. A coordinated review should assess safety, support and the treatment approach, then explain the next options. It should leave room for uncertainty without requiring a simplified recovery narrative.

Before discharge, confirm the next clinicians and appointments. Identify whom to contact with concerns and how medication or medical monitoring will continue. The plan should be concrete enough for both the person and the receiving team to use.

Is a Swiss hospital always the best choice for dual diagnosis?

The setting should follow the clinical assessment. Hospital, outpatient and residential services serve different needs. Ask which level is appropriate and why.

Can a person begin assessment without a settled diagnosis?

Yes. Start with the symptoms, substance use and history you can describe. The assessment should identify priorities and explain what remains to be clarified.

Does COGNIFUL provide treatment in Switzerland?

The residence described here is in Mallorca, Spain. Swiss residents should agree on an appropriate local handover and confirm the scope of any international follow-up.

How should medication be handled during a move between services?

Identify the responsible prescriber and monitoring arrangements at each stage. Do not change treatment independently because the setting changes; ask the clinicians to coordinate and explain the plan.

1. Finding Help for Co-Occurring Substance Use and Mental Disorders — National Institute of Mental Health.
2. Addiction and Dual Diagnoses — Psychiatric University Hospital Zurich.
3. Center for Addiction Disorders — Psychiatric Services Aargau.
4. Private Dual Diagnosis Treatment and Co-Occurring Needs — COGNIFUL.
5. Clinical Practice Guideline on Alcohol Withdrawal Management — American Society of Addiction Medicine.
6. Opioid Use Disorder: Treating — Centers for Disease Control and Prevention.
7. Clinical Scope, Suitability and Care Coordination — COGNIFUL.
8. How Residential Treatment Works — COGNIFUL.
9. Programs, Fees and Admissions — COGNIFUL.
10. Continuing Care and Reintegration — COGNIFUL.